We are pleased to welcome Brinter AM Technologies Oy as the newest member of the Finnish Additive Manufacturing Ecosystem (FAME).
Founded in Finland in 2018, Brinter began with a bold vision inspired by science fiction: What if human tissue could be 3D bioprinted? Since then, the company has grown into a pioneer in advanced 3D bioprinting technologies, developing solutions for industrial, medical and research applications while advancing regenerative medicine towards commercialization.
“Brinter AM Technologies Oy is pleased to join the Finnish Additive Manufacturing Ecosystem, FAME. As a company developing advanced 3D printing technologies for industrial, medical and research applications, we see strong value in being part of a national ecosystem that brings together Finnish expertise across the additive manufacturing value chain. Through FAME, we hope to strengthen collaboration, increase visibility for Finnish AM capabilities internationally, and contribute to building a more competitive and innovative additive manufacturing sector in Finland,” says Tomi Kalpio, CEO of Brinter AM Technologies Oy.
“We are delighted to welcome Brinter to the FAME ecosystem. Brinter represents the kind of ambitious Finnish innovation that demonstrates how additive manufacturing can transform entire industries, from healthcare to advanced manufacturing. Their pioneering work in 3D bioprinting strengthens our network and reinforces our shared mission of increasing the international visibility and competitiveness of Finnish additive manufacturing through collaboration,” says Eetu Holstein, Senior Ecosystem Lead at FAME.
